Related Experiment Video
Updated: Apr 4, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Seek and Ye Shall Find: Subclonal Anaplastic Lymphoma Kinase Mutations
1Department of Pediatric Hematology and Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. rani_george@dfci.harvard.edu.
Abstract:
Bellini and colleagues demonstrate the importance of next-generation sequencing to uncover subclonal anaplastic lymphoma kinase (ALK) mutations in neuroblastoma. Although the significance of these subclonal aberrations is not yet understood, deep sequencing could identify patients whose tumors may respond to ALK inhibitors.
Insights
Next-generation sequencing can find hidden anaplastic lymphoma kinase (ALK) mutations in neuroblastoma. This deep sequencing approach may help identify patients eligible for ALK inhibitor therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Neuroblastoma is a pediatric cancer characterized by genetic heterogeneity.
- Anaplastic lymphoma kinase (ALK) mutations are implicated in neuroblastoma development and progression.
- Targeted therapies for neuroblastoma are under development, necessitating precise patient stratification.
Purpose of the Study:
- To highlight the utility of next-generation sequencing (NGS) in detecting subclonal anaplastic lymphoma kinase (ALK) mutations in neuroblastoma.
- To explore the potential of deep sequencing for identifying patients who may benefit from ALK inhibitors.
Main Methods:
- Utilized next-generation sequencing (deep sequencing) to analyze tumor samples.
- Focused on the detection of subclonal mutations within the anaplastic lymphoma kinase (ALK) gene.
Main Results:
- Successfully uncovered subclonal anaplastic lymphoma kinase (ALK) mutations using deep sequencing.
- Demonstrated the capability of NGS to identify genetic aberrations previously missed by other methods.
Conclusions:
- Next-generation sequencing is crucial for a comprehensive understanding of neuroblastoma's genetic landscape.
- Deep sequencing holds promise for identifying patients with actionable ALK mutations for targeted therapy.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

